|
Evaluation of complete response rate at 30 months (CR30) as a surrogate for progression-free survival (PFS) in first-line follicular lymphoma (FL) studies: Results from the prospectively specified Follicular Lymphoma Analysis of Surrogacy Hypothesis (FLASH) analysis with individual patient data (IPD) of 3,837 patients (pts). |
|
|
Research Funding - Celgene; Roche Pharma AG |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - Celgene |
Research Funding - Celgene |
|
|
Consulting or Advisory Role - Algeta ASA; OptumRx; Seagen |
Research Funding - Acerta Pharma (Inst); Celgene (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Infinity Pharmaceuticals (Inst); Janssen Oncology (Inst); Onyx (Inst); Pharmacyclics (Inst); Spectrum Pharmaceuticals (Inst); TG Therapeutics (Inst) |
Other Relationship - Celgene |
|
|
Consulting or Advisory Role - Celgene; Gilead Sciences; Pharmacyclics; Roche Pharma AG |
Research Funding - Celgene; Gilead Sciences; Pharmacyclics; Roche Pharma AG |
|
|
|
Stock and Other Ownership Interests - Celgene |
|
|
|
Consulting or Advisory Role - Millennium |
|
|
No Relationships to Disclose |
|
|
Research Funding - Celgene |
|
|
Employment - Roche/Genentech |
|
|
Honoraria - Gilead Sciences; Janssen; Pharmacyclics |
Consulting or Advisory Role - Bayer; Roche Pharma AG |
Research Funding - Pfizer |
|
|
Honoraria - Argon Medical Devices; Celgene; Mundipharma; Roche Pharma AG; Teva |
Consulting or Advisory Role - Argon Medical Devices; Celgene; Mundipharma; Roche Pharma AG; Teva |
Research Funding - Argon Medical Devices; Celgene; Mundipharma; Roche Pharma AG |
|
|
|
Consulting or Advisory Role - Celgene |
Travel, Accommodations, Expenses - Celgene |
|
|
Employment - Celgene; Roche Pharma AG |
Stock and Other Ownership Interests - Celgene |
|
|
|
Stock and Other Ownership Interests - Celgene |
Research Funding - Celgene |
Travel, Accommodations, Expenses - Celgene |
|
|
|
Stock and Other Ownership Interests - Roche Pharma AG |
|
|
Honoraria - Celgene; Mundipharma; Roche Pharma AG |
Consulting or Advisory Role - Celgene; Janssen; Roche Pharma AG |
Speakers' Bureau - Celgene; Janssen; Mundipharma; Roche Pharma AG |
Research Funding - Celgene |
|
|
Consulting or Advisory Role - Celgene; Janssen; Roche Pharma AG |
Research Funding - Celgene; Mundipharma; Roche Pharma AG |
|
|
Honoraria - Amgen; Mundipharma; Roche/Genentech; Sanofi |
Consulting or Advisory Role - Celgene; Gilead Sciences; Janssen; Mundipharma; Roche/Genentech |
Research Funding - Roche/Genentech (Inst) |
Travel, Accommodations, Expenses - Roche/Genentech |